Cipro and Conjunctival haemorrhage - a phase IV clinical study of FDA data

Summary:

Conjunctival haemorrhage is reported as a side effect among people who take Cipro (ciprofloxacin hydrochloride), especially for people who are male, 60+ old, have been taking the drug for 2 - 5 years also take Coumadin, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Conjunctival haemorrhage when taking Cipro. It is created by eHealthMe based on reports of 32,835 people who have side effects when taking Cipro from the FDA, and is updated regularly.

What is Cipro?

Cipro has active ingredients of ciprofloxacin hydrochloride. It is often used in urinary tract infection. eHealthMe is studying from 35,126 Cipro users. Check the latest studies of Cipro.

What is Conjunctival haemorrhage?

Conjunctival haemorrhage (bleeding underneath the conjunctiva) is found to be associated with 510 drugs and 561 conditions by eHealthMe. Check the latest studies of Conjunctival haemorrhage.

On Jul, 18, 2026

32,835 people reported to have side effects when taking Cipro.
Among them, 29 people (0.09%) have Conjunctival haemorrhage.

Could Cipro cause Conjunctival haemorrhage?

Among these 29 people:

How long have people been on Cipro when they have Conjunctival haemorrhage? *

What is the gender of people who have Conjunctival haemorrhage when taking Cipro? *

female: 10.34 %
male: 89.66 %

What is the age of people who have Conjunctival haemorrhage when taking Cipro? *

What are other drugs people take besides Cipro? *

What are other side effects people have besides Conjunctival haemorrhage? *

Anaemia (lack of blood): 24 people, 82.76%
Oedema Peripheral (superficial swelling): 23 people, 79.31%
Stress And Anxiety: 23 people, 79.31%
Toothaches (tooth pain): 22 people, 75.86%
Back Pain: 21 people, 72.41%
Bone Disorder: 20 people, 68.97%
Neuropathy Peripheral (surface nerve damage): 18 people, 62.07%
Atelectasis (partial or complete collapse of the lung): 16 people, 55.17%
Pain: 15 people, 51.72%
Neoplasm Malignant (cancer tumour): 14 people, 48.28%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 10 people, 34.48%
Bone Density Decreased: 9 people, 31.03%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 8 people, 27.59%
Neoplasm Malignant (cancer tumour): 7 people, 24.14%
Bone Loss: 3 people, 10.34%
Iron Overload: 2 people, 6.90%
Urinary Incontinence (inability to control the flow of urine and involuntary urination): 1 person, 3.45%
Chest Pain: 1 person, 3.45%
Arteriosclerosis Coronary Artery (thickening and hardening of arteries- coronary artery): 1 person, 3.45%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 1 person, 3.45%

* Approximation only. Some reports may have incomplete information.

Do you take Cipro and have Conjunctival haemorrhage?

- Check whether Conjunctival haemorrhage is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cipro:

Cipro (35,126 reports)

Browse all side effects of Cipro:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Conjunctival haemorrhage:

Conjunctival haemorrhage (510 drugs)

Browse all the conditions that are associated with Conjunctival haemorrhage:

Conjunctival haemorrhage (561 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ciprofloxacin hydrochloride (the active ingredients of Cipro) and Cipro (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.